e15v12g
 

United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

Certification and Notice of Termination of Registration
under Section 12(g) of the Securities Exchange Act
of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities
Exchange Act of 1934.

Commission File Number 000-05958

Meridian Medical Technologies, Inc.

(Exact name of registrant as specified in its charter)

10240 Old Columbia Road, Columbia, Maryland, 21046
(443) 259-7800

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.10 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under
section 13(a) or 15(d) remains)

     Please place an X in the box (es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

             
Rule 12g-4 (a) (1) (i)   [X]   Rule 12h-3 (b) (1) (ii)   [  ]
Rule 12g-4 (a) (1) (ii)   [  ]   Rule 12h-3 (b) (2) (i)   [  ]
Rule 12g-4 (a) (2) (i)   [  ]   Rule 12h-3 (b) (2) (ii)   [  ]
Rule 12g-4 (a) (2) (ii)   [  ]   Rule 15d-6   [  ]
Rule 12h-3 (b) (1) (i)   [X]        

 

 

     Approximate number of holders of record as of the certification or notice date: 1

     Pursuant to the requirements of the Securities Exchange Act of 1934, Meridian Medical Technologies, Inc., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

             
DATE:   January 8, 2003   By:   /s/ Steven Kaplan
 
            Counsel to Meridian Medical
    Technologies, Inc.